Oncolytics Biotech diskutieren
Oncolytics Biotech
WKN: A2JMW5 / Symbol: ONCY / Name: Oncolytics Bio / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
1,61 €
-4,73 %
Oncolytics Biotech Inc. (NASDAQ: ONCY) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
Ratings data for ONCY provided by MarketBeat
Oncolytics Biotech Inc. (NASDAQ: ONCY) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $6.00 to $5.00. They now have a "buy" rating on the stock.
Ratings data for ONCY provided by MarketBeat
Oncolytics Biotech Inc. (NASDAQ: ONCY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Ratings data for ONCY provided by MarketBeat
Oncolytics Biotech Inc. (NASDAQ: ONCY) had its price target lowered by analysts at HC Wainwright from $15.00 to $5.00. They now have a "buy" rating on the stock.
Ratings data for ONCY provided by MarketBeat
Oncolytics Biotech Inc. (NASDAQ: ONCY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Ratings data for ONCY provided by MarketBeat
Oncolytics Biotech Inc. (NASDAQ: ONCY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Ratings data for ONCY provided by MarketBeat
Oncolytics Biotech Inc. (NASDAQ: ONCY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Ratings data for ONCY provided by MarketBeat
Oncolytics Biotech Inc. (NASDAQ: ONCY) is now covered by analysts at Raymond James. They set an "outperform" rating and a $3.00 price target on the stock.
Ratings data for ONCY provided by MarketBeat
Oncolytics Biotech Inc. (NASDAQ: ONCY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Ratings data for ONCY provided by MarketBeat
Oncolytics Biotech Inc. (NASDAQ: ONCY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Ratings data for ONCY provided by MarketBeat
Oncolytics Biotech Inc. (NASDAQ: ONCY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Ratings data for ONCY provided by MarketBeat
Neueste Beiträge
B__Riley in Matthews International Corp. diskutieren